Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-04FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD by Lannett Company, Inc., a controlled-delivery formulation of …
-
FDA approval · 2017-01-04FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for dextroamphetamine sulfate from Prasco Laboratories.
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application to add dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amph…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for a generic combination of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for a generic combination of dextroamphetamine and amphetamine salts manufactured by Sandoz Inc.
-
FDA approval · 2017-01-04FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc. to support lab…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
FDA approved a supplemental application for the generic dextroamphetamine from Cranbury Pharmaceuticals, confirming continued approval of th…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for a generic combination amphetamine product (dextroamphetamine saccharate/amphetamine aspartat…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for a generic product containing the four amphetamine salt components: dextroamphetamine saccharate,…
-
FDA approval · 2017-01-04FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved a supplemental application for Methylphenidate Hydrochloride by Lupin Pharmaceuticals, Inc., updating an aspect of the prod…
-
FDA approval · 2017-01-04FDA Approved: APTENSIO XR — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA has approved a supplemental NDA for Aptensio XR (methylphenidate hydrochloride) from Rhodes Pharmaceuticals, reflecting regulatory a…
-
FDA approval · 2017-01-04FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the Methylphenidate Transdermal System submitted by Padagis US LLC.
-
FDA approval · 2017-01-04FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) submitted by Amneal Pharmaceuticals LLC.
-
FDA approval · 2017-01-04FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for methylphenidate hydrochloride products from Sandoz Inc.
-
FDA approval · 2017-01-04FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for RITALIN (methylphenidate hydrochloride) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for dextroamphetamine sulfate (SpecGx LLC), resulting in approval for a generic version of the drug.…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application by Wilshire Pharmaceuticals, Inc. for dextroamphetamine sulfate, enabling a generic version of t…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Aurolife Pharma, LLC)
FDA approves a supplemental application for a generic form of dextroamphetamine sulfate by Aurolife Pharma, enabling its market authorizatio…
-
FDA approval · 2017-01-04FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
FDA has approved a supplemental application for DYANAVEL XR (amphetamine) from NextWave Pharmaceuticals, Inc. This approval modifies the NDA…
-
FDA approval · 2017-01-04FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) filed by Sandoz Inc., resulting in changes to the…
-
FDA approval · 2017-01-04FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EVEKEO, a brand-name amphetamine sulfate product from Azurity Pharmaceuticals, under ANDA 200166…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for a generic fixed-dose combination of four amphetamine salts (dextroamphetamine saccharate, amphet…
-
FDA approval · 2016-12-27FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for a generic dextroamphetamine sulfate product.
-
FDA approval · 2016-12-27FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for methylphenidate hydrochloride (a generic product) under ANDA204115.